We recently observed that the LDL receptor-related protein 1 (LRP-1) is tyrosine phosphorylated in v-Srctransformed cells. Using a GST-fusion protein containing the cytoplasmic domain of LRP-1, we show that LRP-1 is a direct substrate for v-Src in vitro. To study LRP-1 phosphorylation in vivo, we constructed an LRP-1 minireceptor composed of the b chain linked at the aminoterminus to a Myc epitope (Myc-LRPb). When expressed together with v-Src, Myc-LRPb becomes phosphorylated on tyrosine. Of the four tyrosine residues present in the cytoplasmic domain of LRP-1, only Tyr 63 is phosphorylated by v-Src in vivo or in vitro. Using fibroblasts deficient in Src, Yes and Fyn, we were able to show that there are multiple kinases present in the cell that can phosphorylate LRP-1. Tyrosine-phosphorylated LRP-1 associates with Shc, a PTB and SH2 domain containing signaling protein that is involved in the activation of Ras. Binding of the purified Shc PTB domain to Tyr 63 containing peptides shows that the interaction between LRP-1 and Shc is direct. We found that DAB, a PTB domain containing signaling protein that is involved in signaling by LDL receptor-related proteins in the nervous system, did not bind to full-length LRP-1. Our observations suggest that LRP-1 may be involved in normal and malignant signal transduction through a direct interaction with Shc adaptor proteins.
Introduction
The LDL receptor-related protein 1 (LRP-1) is a cell surface receptor that mediates internalization of a large number of proteins and lipoproteins including ApoEcontaining lipoproteins, very-low density lipoproteins, chylomicron remnants, activated a 2 macroglobulin, and the amyloid precursor protein (Gliemann et al., 1994; Hussain et al., 1999) . LRP-1 is composed of an a chain that contains 3924 amino acids and a b chain that contains 601 amino acids (Herz et al., 1988) . The a chain is entirely extracellular and contains the ligand binding sites. The b chain consists of an extracellular domain, a transmembrane domain, and a cytoplasmic domain composed of 100 amino acids. The cytoplasmic domain contains four tyrosine residues, two of which are present in the context of N-P-X-Y motifs (in which X represents any amino acid, Figure 1a ). The N-P-X-Y motifs present in the cytoplasmic domain were believed to act as docking sites during clathrin-dependent internalization (Trowbridge et al., 1993; Heilker et al., 1999) . We have found recently that LRP-1 is tyrosine phosphorylated in v-Src-transformed cells (Barnes et al., 2001) . Tyrosine-phosphorylated LRP-1 associates with Shc, a signaling protein that is thought to mediate Ras activation by protein-tyrosine kinases (Bonfini et al., 1996; Barnes et al., 2001) .
Src is a nonreceptor protein-tyrosine kinase that was originally identified as the transforming protein of an oncogenic retrovirus (Martin, 1970 (Martin, , 2001 ). It contains a unique amino-terminal region followed by a Srchomology 3 (SH3) domain, a Src-homolgy 2 (SH2) domain, a kinase domain, and a short tail that contains a phosphorylation site at Tyr 527 (Brown and Cooper, 1996; Biscardi et al., 1999; Abram and Courtneidge, 2000) . The SH3 domain binds to Pro-rich sequences and is thought to be involved in regulation of kinase activity and substrate binding (Hirai and Varmus, 1990; Liu et al., 1993; Weng et al., 1994) . The SH2 domain binds to phosphorylated tyrosine residues within the context of a Y-E-E-I motif (Songyang et al., 1993) . Binding of the Src SH2 domain to Tyr 527 helps to maintain Src in an inactive conformation (Sicheri et al., 1997; Xu et al., 1997) . Deletion of the carboxy-terminus or mutation of Tyr 527 yields an oncogenically active protein-tyrosine kinase (Cartwright et al., 1987; Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987) . Exactly which Src substrates mediate oncogenic transformation remains to be discovered. However, it is known that transformation by v-Src depends on the activation of Ras (Smith et al., 1986) .
In normal cells, Src-like protein tyrosine kinases are thought to be involved in signal transduction by a variety of cell surface receptors including receptor protein-tyrosine kinases, integrins, and G proteincoupled receptors (Brown and Cooper, 1996; Biscardi et al., 1999; Abram and Courtneidge, 2000) . The interaction between Src and activated growth factor receptors has been well documented, and activation of Src following engagement of integrins or G proteincoupled receptors has been studied in great detail (Luttrell et al., 1988 (Luttrell et al., , 1999 Kypta et al., 1990; Courtneidge et al., 1993; Zhan et al., 1994; Schlaepfer and Hunter, 1998; Giancotti and Ruoslahti, 1999) . Analysis of mutant fibroblasts that lack Src-like kinases (SYF cells) showed that they are dispensable for normal signaling by the PDGF receptor (Klinghoffer et al., 1999) . In contrast, signal transduction by integrins was found to be highly dependent on the presence of these Src-like kinases (Klinghoffer et al., 1999) .
Shc is an adaptor protein that is involved in signaling by receptor and nonreceptor protein-tyrosine kinases (Ravichandran, 2001) . Shc proteins contain an aminoterminal PTB domain, a central region containing several tyrosine phosphorylation sites, and a carboxyterminal SH2 domain Luzi et al., 2000) . The Shc PTB domain binds to phosphorylated f-X-N-P-X-Y motifs (in which f represents large nonpolar residues, and X represents any residue) (Songyang et al., 1995; Zhou et al., 1995; van der Geer et al., 1996a) . The Shc SH2 domain binds to phosphorylated tyrosine residues in the context of acidic or nonpolar residues carboxy-terminal to the tyrosine (Songyang et al., 1994) . Tyrosine phosphorylation sites on Shc function as binding sites for other signaling proteins, including Grb2 (Rozakis-Adcock et al., 1992; Cutler et al., 1993; van der Geer et al., 1996b) . It is through the interaction with the Grb2-Sos complex that Shc is thought to be involved in the activation of Ras (Rozakis-Adcock et al., 1992; Pawson, 1995; Lai and Pawson, 2000) .
The observations that LRP-1 is tyrosine phosphorylated in v-Src-transformed cells and that tyrosinephosphorylated LRP-1 associates with Shc suggest that it may be active as a mediator of signal transduction. This is consistent with recent work showing that two other LDL receptor-related proteins, the ApoE receptor 2 and the VLDL receptor, are involved in relaying guidance cues to migrating neurons during development (Trommsdorff et al., 1999) . Both the ApoE receptor 2 and the VLDL receptor contain a single N-P-X-Y motif in their cytoplasmic domain that may function as a binding site for disabled (DAB) (Takahashi et al., 1992; Kim et al., 1996; Howell et al., 1999) . DAB is a PTB domain-containing adaptor protein that is expressed primarily in the nervous system (Howell et al., 1997) .
In this study we have identified Tyr 63 as the main LRP-1 tyrosine phosphorylation site. Tyr 63 acts as the binding site for Shc in vivo and in vitro. Binding is direct and is dependent on phosphorylation. We found that the DAB PTB domain binds in vitro to phosphorylated and unphosphorylated peptides based on the sequence around Tyr 63. Interestingly, the DAB PTB domain did not bind to Tyr 63 in the context of full-length LRP-1. Finally, we have shown that Tyr 63 is a direct substrate for v-Src, but that phosphorylation of LRP-1 in the cell may be carried out by other kinases as well.
Results
We have shown recently that LRP-1 is phophorylated on tyrosine residues in v-Src-transformed cells. To test whether LRP-1 is a direct substrate for v-Src, we generated a GST-fusion protein containing the cytoplasmic domain of LRP-1 (GST-LRP, Figure 1b ). This fusion protein was purified and incubated in the presence of v-Src, Mn 2 þ , Mg 2 þ , and ATP. The reaction products were resolved by SDS-PAGE and analysed by anti-P.Tyr (Figure 1c , upper panel) and anti-LRP-1 (Figure 1c, lower panel) immunoblotting. GST-LRP was phosphorylated in the presence, but not in the absence, of v-Src (Figure 1c) . GST did not act as a substrate for v-Src (Figure 1c) . Anti-LRP-1 immunoblotting of the reaction products showed that a large fraction of the GST-LRP shifted in mobility during SDS-PAGE following phosphorylation by v-Src. (Figure 1c ). This indicates a high stochiometry of phosphorylation. These data show that LRP-1 can be The cytoplasmic domain of LRP-1 contains four tyrosine residues (Figure 1a) . Two of these, Tyr 29 and Tyr 63, are present in the context of a f-X-N-P-X-Y motif. To find out which of these tyrosines are phosphorylated by v-Src, Tyr 29 and Tyr 63 were mutated to phenylalanine, thereby producing GST-LRP Phe 29, GST-LRP Phe 63, and the double mutant GST-LRP 2F. Wild-type and mutant fusion proteins were used as substrates for phosphorylation by v-Src in vitro (Figure 1c) . Mutation of Tyr 29 had no effect on the ability of v-Src to phosphorylate GST-LRP. In contrast, mutation of Tyr 63 completely blocked phosphorylation of GST-LRP by v-Src. Mutation of Tyr 63 also blocked the mobility shift that occurs upon incubation with v-Src, suggesting that this change in mobility during SDS-PAGE resulted from phosphorylation at Tyr 63. These results show that v-Src phosphorylates LRP-1 specifically on Tyr 63.
The cDNA that encodes LRP-1 is over 15 kbp long and is therefore very difficult to manipulate. In order to study LRP-1 phosphorylation site mutants in vivo, we constructed a cDNA encoding Myc-LRPb, in which the b chain of LRP-1 is linked at the amino-terminus to a signal peptide and a Myc epitope (Figure 2a To find out which tyrosine residues in the cytoplasmic domain of LRP-1 are phosphorylated in v-Src-expressing cells, Tyr 29 and Tyr 63 were mutated in the context of Myc-LRPb. Wild-type and mutant proteins were expressed transiently in the absence or presence of v-Src. Anti-P.Tyr blots of anti-Myc immunoprecipitates showed that mutation of Tyr 29 resulted in a small decrease in tyrosine phosphorylation, whereas mutation of Tyr 63 completely blocked tyrosine phosphorylation (Figure 3a) . Anti-LRP-1 blots showed that all proteins were expressed at similar levels ( Figure 3b ). These data indicate that Tyr 63 is the main tyrosine phosphorylation site on LRP-1 in v-Src-expressing cells.
We observed recently that tyrosine-phosphorylated LRP-1 associates with Shc. To find out whether Tyr 63 can act as a binding site for Shc, we designed a peptide based on the sequence around Tyr 63 (Figure 4b ). Both the phosphorylated and unphosphorylated peptides were linked to Sepharose beads and tested for their ability to bind to Shc (Figure 4a ). Sepharose beads were incubated with lysates of A172 human glioblastoma cells that had been treated with orthovanadate and hydrogen peroxide. Bound proteins were resolved by SDS-PAGE and Shc was detected by anti-Shc and anti-P.Tyr immunoblotting (Figure 4a ). All three isoforms of Shc (p46, p52, and p66) bound selectively to the phosphorylated peptide. The unphosphorylated control peptide displayed a considerably lower ability to bind to Shc. These data show that Tyr 63 in the cytoplasmic domain of LRP-1 can act as a binding site for Shc.
To prove that Tyr 63 acts as the Shc-binding site in the context of the full-length LRP-1 b chain, wild-type and mutant Myc-LRPb proteins were expressed transiently in 293 T cells and Shc immunoprecipitates were analysed by anti-Myc immunoblotting (Figure 5a ). All mutants were expressed at similar levels ( Figure 5b ). Our (Figure 5a ). This indicates that the association between Shc and LRP-1 is dependent on LRP-1 tyrosine phosphorylation. Mutation of Tyr 29 did not affect the ability of Myc-LRPb to bind to Shc, while mutation of Tyr 63 completely blocked the ability of Myc-LRPb to coimmunoprecipitate with Shc. These observations show that Tyr 63 is the primary Shc-binding site in LRP-1 in vivo.
To confirm this result in an independent experiment, lysates of 293 T cells transiently expressing wild-type or mutant Myc-LRPb proteins were incubated with a GST-Shc PTB domain fusion protein immobilized on glutathione-agarose. Anti-Myc immunoblotting showed that the wild-type protein bound nicely to the Shc PTB domain, but only when expressed together with v-Src (Figure 5c ). Mutation of Tyr 29 had no effect on the ability of Myc-LRPb to bind to the Shc PTB domain, while mutation of Tyr 63 completely blocked binding. These data show that while the cytoplasmic domain of LRP-1 contains two f-X-N-P-X-Y motifs, only Tyr 63 can mediate the interaction between LRP-1 and Shc.
The experiments described thus far have not ruled out the possibility that the association between LRP-1 and Shc is indirect. To prove that the Shc PTB domain binds directly to Tyr 63, we asked whether the purified Shc PTB domain binds to synthetic Tyr 63 peptides. Phosphorylated and unphosphorylated Tyr 63 peptides immobilized on Sepharose beads were incubated with the purified GST-Shc PTB domain fusion protein, the Sepharose beads were subsequently washed and bound proteins were analysed by SDS-PAGE and Coomassie Blue staining (Figure 6 ). Since there is some evidence that DAB also binds to Tyr 63, the DAB PTB domain was analysed in parallel. The Shc PTB domain bound directly to the Tyr 63 peptide and binding was completely dependent on phosphorylation of Tyr 63 ( Figure 6, lanes 3 and 4) . In contrast, the DAB PTB bound equally well to the phosphorylated and the unphosphorylated Tyr 63 peptide (Figure 6, lanes 1 and  2) . These results show that the PTB domains of both Shc and DAB bind directly to peptides based on the LRP-1 Tyr 63 phosphorylation site.
To find out whether the DAB PTB domain can bind to Tyr 63 in the context of the full-length LRP-1, cell lysates were incubated with GST-DAB PTB fusion protein immobilized on glutathione-agarose and bound proteins were analysed by anti-LRP-1 immunoblotting. The Shc PTB domain was analysed in parallel as a positive control. Lysates were obtained from control (14.30) and Src-transformed (14.30S3) fibroblasts. The Shc PTB domain bound to LRP-1 present in lysates obtained from control fibroblasts, but only after treatment with orthovanadate and hydrogen peroxide (Figure 7a ). Binding to LRP-1 from Src-transformed fibroblasts was largely independent of, but could be increased by, treatment with orthovanadate and hydrogen peroxide (Figure 7a ). We did not observe any detectable binding of the DAB PTB domain to either phosphorylated or unphosphorylated LRP-1 (Figure 7a ). This was unexpected because we had found that the DAB PTB domain does bind to the Tyr 63 peptide. To test for biological activity of the DAB PTB domain, proteins bound to the immobilized fusion proteins were analysed by anti-P.Tyr immunoblotting (Figure 7b ). These results show that while the DAB PTB domain Figure 6 Direct binding of the Shc and DAB PTB domains to peptides based on the Tyr 63 phosphoryation site. Phosphorylated and unphosphorylated peptides based on the sequence around the Tyr 63 phosphorylation site were immobilized on Sepharose beads (Figure 4b ). Peptides were incubated with purified GST-PTB domain fusion proteins at 5 mm in PLC-lysis buffer. The Sepharose beads were washed and bound proteins were analysed by SDS-PAGE and Coomassie Blue staining Thus far we have examined LRP-1 phosphorylation only in cells expressing the oncogenic v-Src proteintyrosine kinase. The results discussed above suggest that LRP-1 can be tyrosine phosphorylated in normal fibroblasts. To address this directly, 14.30 mouse fibroblasts were starved overnight in serum-free medium and stimulated with EGF, PDGF or orthovanadate, and hydrogen peroxide. LRP-1 was isolated by imunoprecipitation and analysed by anti-P.Tyr (Figure 8a ) and anti-LRP-1 immunoblotting (Figure 8b) . As a control for growth factor receptor activation, wholecell lysates were analysed by anti-P.Tyr immunoblotting (Figure 8c ). We observed low levels of LRP-1 tyrosine phosphorylation in serum-starved fibroblasts (Figure 8a ). Stimulation with either EGF or PDGF did not increase the level of LRP-1 tyrosine phosphorylation (Figure 8a ). In contrast, inhibition of cellular protein tyrosine phosphatases with orthovanadate and hydrogen peroxide resulted in a large increase in LRP-1 tyrosine phosphorylation. Similar observations were made in other fibroblast cell lines (data not shown). The presence of tyrosine-phosphorylated LRP-1 in control fibroblasts suggests that LRP-1 tyrosine phosporylation does not depend on the presence of activated Src. It was unexpected to find that activation of growth factor receptor protein-tyrosine kinases did not result in a further increase in LRP-1 tyrosine phosphorylation.
To investigate the role of Src-family kinases in LRP-1 phosphorylation, we analysed LRP-1 phosphorylation in SYF cells, which lack functional genes for Src, Yes, and Fyn (Klinghoffer et al., 1999) . SYF cells expressing c-Src from a retroviral vector (SYF-Src) were analysed in parallel (Klinghoffer et al., 1999) . LRP-1 was immunoprecipitated and analysed by anti-P.Tyr and anti-LRP-1 immunoblotting (Figure 9 ). We observed some LRP-1 tyrosine phosphorylation in untreated SYF cells and tyrosine phosphorylation went up following treatment with orthovanadate and hydrogen peroxide (Figure 9 ). LRP-1 tyrosine phosphorylation in orthovanadate and hydrogen peroxide treated SYF-Src cells was somewhat higher than in similarly treated SYF cells (Figure 9 ). These results suggest that Src-family kinases can contribute to LRP-1 phosphorylation, but that they may not represent the principle LRP-1 tyrosine kinases present in normal cells. 1994; Hussain et al., 1999) . LRP-1 is composed of an a chain and a b chain. The a chain is entirely extracellular and contains the ligand-binding sites. The b chain is comprised of an extracellular domain, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain contains 100 amino-acid residues, including four tyrosines (Figure 1a) . We have shown recently that the b chain of LRP-1 is phosphorylated on tyrosine residues in v-Src-transformed cells (Barnes et al., 2001 ).
Here we have shown that LRP-1 can be phosphorylated directly by v-Src in vitro. Although there are four tyrosine residues present in its cytoplasmic domain, our data show that Tyr 63 is the sole v-Src phosphorylation site in LRP-1. This is interesting because Tyr 29 and Tyr 63 are present within a very similar sequence context (Figure 1a) . We further observed that Tyr 29 became a substrate for v-Src upon denaturation of the GST-LRP fusion protein (H Barnes and P van der Geer, unpublished observations). This suggests that Tyr 29 is not phosphorylated in the native protein because it is not accessible.
Mutation of Tyr 63 in the context of the Myc-LRPb minireceptor completely abolishes tyrosine phosphorylation of LRP-1 in v-Src-transformed cells. This suggests that Tyr 63 is the principle phosphorylation site in vivo. We observed some decrease in LRP-1 tyrosine phosphorylation upon mutation of Tyr 29. This raises the possibility that Tyr 29 is also a target for phosphorylation or that mutation at Tyr 29 somehow affects phosphorylation at Tyr 63.
Mutation of Tyr 63 completely blocks binding of Shc to LRP-1, whereas mutation of Tyr 29 has no effect. A phosphopeptide based on the sequence around Tyr 63 binds to Shc present in cell lysates and to the purified Shc PTB domain. These observations indicate that Shc uses its PTB domain to bind directly to Tyr 63 in the cytoplasmic domain of LRP-1. This is consistent with the fact that Tyr 63 is present in the context of a f-X-N-P-X-Y motif (Figure 1a ). This sequence has been identified previously as a binding site for the Shc PTB domain (van der Geer et al., 1996a) . While Tyr 29 is also present within the context of a f-X-N-P-X-Y motif, it is not phosphorylated in v-Src-expressing cells and does not act as a binding site for the Shc PTB domain. It is of interest that the sequence around Tyr 29 has been highly conserved during evolution (Nimpf et al., 1994; Gellner and Brenner, 1999) .
DAB is an adaptor protein that is preferentially expressed in the nervous system (Howell et al., 1997) . DAB contains a PTB domain that was found to bind specifically to unphosphorylated N-P-X-Y motifs (Howell et al., 1999) . We found that the DAB PTB domain binds equally well to phosphorylated and unphosphorylated Tyr 63 peptides. In support of this observation, we also found that the DAB PTB domain also binds to several tyrosine-phosphorylated proteins present in lysates of v-Src-transformed cells. It is not clear why our results differ from those that were published previously (Howell et al., 1999) . One possible explanation is that we used peptides that were bound to Sepharose beads, while Cooper and co-workers used peptides that were synthesized directly onto cellulose membranes (Howell et al., 1999) .
Although the DAB PTB domain binds well to Tyr 63-containing peptides, we did not observe any binding to the full-length LRP-1 b chain. This suggests that not all residues around Tyr 63 that contribute to the interaction between the peptide and the DAB PTB domain are accessible to the DAB PTB domain in the full-length b chain. Alternatively, it is possible that the conformation of the polypeptides chain around Tyr 63 in the context of the LRP-1 b chain is incompatible with DAB PTB binding. Both the Shc and the DAB PTB domains bind to a number of tyrosine-phoshorylated proteins present in lysates of Src-transformed cells. When comparing the Shc and the DAB PTB domain, we found that the Shc PTB domain has a broader, but completely overlapping specificity. This suggests the possibility that the binding site for the DAB PTB domain extends beyond that of the Shc PTB domain.
Our results are in conflict with previously published data that show binding of the DAB PTB domain to fulllength LRP-1 (Trommsdorff et al., 1998) . The most obvious difference between the two experiments is that we incubated PTB domain containing fusion proteins for 30 min with cell lysates containing LRP-1. In the previously published experiment, PTB domain containing fusion proteins were incubated for 6 h with LRP-1 containing lysates (Trommsdorff et al., 1998) . It is possible that binding of the DAB PTB to LRP-1 has a very slow on-rate. Alternatively, it is possible that some of the LRP-1 denatures during the prolonged incubation times, thereby giving access to additional residues that may be important for the interaction between DAB and LRP-1.
LRP-1 is tyrosine phosphorylated to some extent in control fibroblasts and phosphorylation increases considerably following treatment with orthovanadate and hydrogen peroxide. This shows that LRP-1 tyrosine phosphorylation is independent of the presence of the oncogenically activated v-Src protein-tyrosine kinase. Interestingly, we did not observe an increase in LRP-1 tyrosine phosphorylation following stimulation with either EGF or PDGF. This is of interest because Src is thought to be involved in signal transduction by receptor protein-tyrosine kinases, including the EGF receptor and the PDGF receptor (Luttrell et al., 1988 (Luttrell et al., , 1994 Kypta et al., 1990; Courtneidge et al., 1991) . This suggests that perhaps only a small fraction of Src is activated following growth factor receptor activation or that the fraction of Src that is activated is not localized in proximity to LRP-1.
What is the identity of the kinases that phosphorylate LRP-1? The observation that LRP-1 is phosphorylated in v-Src-transformed cells suggests that v-Src can phosphorylate LRP-1. This is consistent with in vitro phosphorylation of LRP-1 by Src. Immunodepletion experiments (results not shown) and orthovanadate and hydrogen peroxide induced tyrosine phosphorylation of LRP-1 in SYF fibroblasts suggest that LRP-1 can be phosphorylated in the absence of Src-like kinases. This v-Src induces Shc binding to tyrosine Helen Barnes et al suggests that LRP-1 can be phosphorylated by a variety of protein-tyrosine kinases.
Our results and those of others indicate that LRP-1 is subject to phosphorylation by v-Src and other unidentified protein-tyrosine kinases. When present in the context of the full-length b chain, Tyr 63 acts as a binding site for the Shc PTB domain but not for the DAB PTB domain. The interaction between LRP-1 and signaling proteins like Shc suggests that LRP-1 may be active as a signal transducing receptor. This lends further credibility to the idea that LDL receptor-related proteins function as important mediators of signal transduction.
Materials and methods

Materials
14.30 cells (van der Geer et al., 1997), SYF and SYF-Src cells (Klinghoffer et al., 1999) , S7A cells (Brooks-Wilson et al., 1989) , and 293T cells were grown in Dulbecco-Vogt-modified Eagle's medium (DMEM) containing 10% calf serum. A172 glioblastoma cells were grown in DMEM containing 10% fetal calf serum (Giard et al., 1973) . The hybridoma 11H4 (obtained from ATCC, Manassas, VA, USA) was grown in Iscovesmodified Dulbecco's medium supplemented with 10% FBS and 25 mm l-glutamine. A polyclonal anti-Shc serum was raised against a GST-Shc SH2 domain fusion protein. Antiphosphotyrosine monoclonal antibody 4G10 and anti-Myc monoclonal antibody 9E10 were purchased from UBI (Lake Pacid, NY, USA) and Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-Src monoclonal antibody 327 was a gift from Dr T Hunter.
GST fusion proteins
The cDNA sequence encoding the complete cytoplasmic domain of LRP-1 was amplified by PCR and cloned in frame into pGEX 4T2. The entire PCR product was sequenced to ensure fidelity. Mutations at Tyr 29 (Phe 29), Tyr 63 (Phe 63), or both (2F) were introduced using the Transformer Sitedirected Mutagenesis Kit (Clonetech, Palo Alto, CA, USA). GST-LRP, GST-DAB PTB and GST-Shc PTB domain fusion proteins were expressed and purified as described (Barnes et al., 2001) .
In vitro kinase reactions
GST fusion proteins were incubated for 15 min at 371C in 20 mm Tris-Cl pH 7.4, 10 mm MnCl 2 , 10 mm MgCl 2 , 1 mm DTT, and 5 mm ATP (kinase buffer) in the presence of vSrc, isolated by immunoprecipitation from S7A cells. When whole-cell lysates were used as a source of kinase activity, fusion proteins immobilized on glutathione-agarose were resuspended in 50 ml 2 Â kinase buffer and 50 ml cell lysate and incubated for 15 min at 371C. Reaction products were analysed by anti-P.Tyr immunoblotting.
Expression of Myc-LRPb in 293 cells
To generate Myc-LRPb, the cDNA encoding the entire LRP-1 b chain was amplified by PCR and linked at the 5 0 end to sequences encoding a signal peptide and a Myc epitope-tag using conventional techniques. The resulting cDNA was cloned into pcDNA3 and sequenced to ensure fidelity. 293 T cells grown on 10 cm tissue culture dishes coated with polylysine were transfected at 30% confluency with 5 mg of pcDNA3-Myc-LRPb using Lipofectin and Optimem (Gibco BRL, Gaithersburg, MD, USA). Cells were lysed 72 h after transfection.
Immunoprecipitation, GST fusion-protein pulldown, and peptidebinding experiments Cells were grown to confluency on 10 cm tissue culture dishes, rinsed twice with cold TBS, and lysed in 1 ml 50 mm HEPES pH 7.5, 150 mm NaCl, 10% glycerol, 1% Triton X-100, 1.5 mm MgCl 2 , 1 mm EGTA, 100 mm NaF, 10 mm sodium pyrophosphate, 500 mm sodium orthovanadate, 1 mm DTT, 10 mg/ml aprotinin, and 10 mg/ml leupeptin (PLC-lysis buffer) per 10 cm tissue culture dish. Lysates were cleared by centrifugation at 10 000 r.p.m. in a microcentrifuge at 41C, incubated with 5 ml polyclonal antiserum or 1 mg monoclonal antibody for 1 h on ice, and subsequently for 1 h with 100 ml 10% Protein ASepharose or anti-mouse IgG-Sepharose for 1 h at 41C on an agitator. Sepharose beads were collected by centrifugation and washed 4 Â with PLC-lysis buffer. Immunoprecipitates were boiled 3 min in 62.5 mm Tris/Cl pH 6.8, 10% glycerol, 5% bmercaptoethanol, 5 mm DTT, 2.3% SDS, and 0.025% bromophenol blue (SDS-sample buffer) and resolved by SDS-PAGE.
For GST-fusion protein pulldown experiments, lysates were incubated by rocking for 1 h at 41C with 100 ml of a 10% slurry of glutathione-agarose beads containing 1-2 mg of a GST fusion protein. Agarose beads were collected by centrifugation, washed 4 Â with PLC-lysis buffer, and bound proteins were resolved by SDS-PAGE.
For peptide-binding experiments, cell lysates or purified fusion proteins were incubated for 30 min at 41C with 100 mg peptide immobilized on 25 ml Sepharose beads (Amersham Bioscience, Piscataway, NJ, USA). Sepharose beads were washed 4 Â with PLC-lysis buffer and bound proteins were resolved by SDS-PAGE.
Immunoblotting
Proteins were transferred to PVDF membranes using a BioRad (Hercules, CA, USA) semi-dry transfer apparatus at 50 mA per gel for 50 min at room temperature. Membranes were blocked for 45 min at room temperature in 10 mm Tris/Cl pH 7.4, 150 mm NaCl, 0.2% Tween 20 (TBS-T) containing 5% milk and then incubated with a 1 : 5 dilution of anti-LRP-1 hybridoma supernatant, a 1 : 200 dilution of the anti-Shc polyclonal, a 1 : 200 dilution of the anti-Myc monoclonal, or a 1 : 1000 dilution of the anti-Src monoclonal in TBS-T with 5% milk for 1 h at room temperature. Blots were washed twice for 10 min in TBS-T and twice for 5 min in TBS. Membranes were then incubated for 30 min with either Protein A-HRP or goat anti-mouse-HRP diluted 1 : 10 000 in TBS-T and washed as before. Reactive proteins were visualized by ECL (Amersham Bioscience, Piscataway, NJ, USA). For immunoblotting with the anti-P.Tyr monoclonal 4G10, membranes were blocked with TBS-T containing 5% bovine serum albumin (BSA) followed by an incubation with the antibody diluted 1 : 200 in TBS-T containing 5% BSA. Washes and detection were done exactly as described for the other antibodies.
